Clarification of the Risk of Chronic Obstructive Pulmonary Disease in α1-Antitrypsin Deficiency PiMZ Heterozygotes

American Journal of Respiratory and Critical Care Medicine

Volumn 189, Issue 4, 2014, Pages 419-427

  Molloy, Kevin ^a   Hersh, Craig P ^b   Morris, Valerie B ^a   Carroll, Tomás P ^a   O'Connor, Catherine A ^a   Lasky Su, Jessica A ^b   Greene, Catherine M ^a   O'Neill, Shane J ^a   Silverman, Edwin K ^b   McElvaney, Noel G ^a  

^a Education and Research Centre ^*  (Ireland)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

1 antitrypsin; Chronic obstructive pulmonary disease; Heterozygote

Indexed keywords

ADULT; AGED; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; FEMALE; FORCED EXPIRATORY VOLUME; GENE-ENVIRONMENT INTERACTION; GENETIC MARKERS; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RISK FACTORS; SMOKING; SPIROMETRY; VITAL CAPACITY;

EID: 84894271236     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201311-1984OC     Document Type: Article

References (37)

1. Thornton Snider J, Romley JA, Wong KS, Zhang J, Eber M, Goldman DP. The disability burden of COPD. COPD 2012;9:513-521.
2. Hutchison DC. Homozygous and heterozygous alpha-1-antitrypsin deficiency: prevalence in pulmonary emphysema. Proc R Soc Med 1976;69:130-131.
3. Carrell RW, Bathurst IC, Brennan SO. The molecular pathology of human alpha 1-antitrypsin. Biochem Soc Symp 1984;49:55-66.
4. Kelly E, Greene CM, Carroll TP, McElvaney NG, O'Neill SJ. Alpha-1 antitrypsin deficiency. Respir Med 2010;104:763-772.
5. Malerba M, Ricciardolo F, Radaeli A, Torregiani C, Ceriani L, Mori E, Bontempelli M, Tantucci C, Grassi V. Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects. Thorax 2006;61:129-133.
6. de Serres FJ, Blanco I. Prevalence of a1-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review. Ther Adv Respir Dis 2012;6:277-295.
7. Carroll TP, O'Connor CA, Floyd O, McPartlin J, Kelleher DP, O'Brien G, Dimitrov BD, Morris VB, Taggart CC, McElvaney NG. The prevalence of alpha-1 antitrypsin deficiency in Ireland. Respir Res 2011;12:91.
8. Seersholm N. Pi MZ and COPD: will we ever know? Thorax 2004;59:823-825.
9. Hersh CP, Dahl M, Ly NP, Berkey CS, Nordestgaard BG, Silverman EK. Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis. Thorax 2004;59:843-849.
10. Foster TS, Miller JD, Marton JP, Caloyeras JP, Russell MW, Menzin J. Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature. COPD 2006;3:211-218.
11. Molloy K, Morris VB, Carroll TP, Silverman EK, Hersh CP, McElvaney NG. The risk of airflow obstruction in PiMZ heterozygotes [abstract]. Am J Respir Crit Care Med 2013;187:A2763.
12. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978;118:1-120.
13. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
14. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC; Official Statement of the European Respiratory Society. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Eur Respir J Suppl 1993;16:5-40.
15. Zerimech F, Hennache G, Bellon F, Barouh G, Jacques Lafitte J, Porchet N, Balduyck M. Evaluation of a new Sebia isoelectrofocusing kit for alpha 1-antitrypsin phenotyping with the Hydrasys System. Clin Chem Lab Med 2008;46:260-263.
16. Lange C, DeMeo D, Silverman EK, Weiss ST, Laird NM. PBAT: tools for family-based association studies. Am J Hum Genet 2004;74: 367-369.
17. Demeo DL, Campbell EJ, Barker AF, Brantly ML, Eden E, McElvaney NG, Rennard SI, Sandhaus RA, Stocks JM, Stoller JK, et al. IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency. Am J Respir Cell Mol Biol 2008;38: 114-120.
18. Dahl M, Tybjaerg-Hansen A, Lange P, Vestbo J, Nordestgaard BG. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population. Ann Intern Med 2002; 136:270-279.
19. Silva GE, Sherrill DL, Guerra S, Barbee RA. A longitudinal study of alpha1-antitrypsin phenotypes and decline in FEV1 in a community population. Chest 2003;123:1435-1440.
20. Sørheim IC, Bakke P, Gulsvik A, Pillai SG, Johannessen A, Gaarder PI, Campbell EJ, Agustí A, Calverley PM, Donner CF, et al. α1-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts. Chest 2010;138:1125-1132.
21. Nsengimana J, Barrett JH. Power, validity, bias and robustness of family-based association analysis methods in the presence of linkage for late onset diseases. Ann Hum Genet 2008;72:793-800.
22. Seersholm N, Wilcke JT, Kok-Jensen A, Dirksen A. Risk of hospital admission for obstructive pulmonary disease in alpha(1)-antitrypsin heterozygotes of phenotype PiMZ. Am J Respir Crit Care Med 2000; 161:81-84.
23. Greene CM, Hassan T, Molloy K, McElvaney NG. The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency. Expert Rev Respir Med 2011;5:395-411.
24. Taggart C, Cervantes-Laurean D, Kim G, McElvaney NG, Wehr N, Moss J, Levine RL. Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J Biol Chem 2000;275:27258-27265.
25. Hubbard RC, Ogushi F, Fells GA, Cantin AM, Jallat S, Courtney M, Crystal RG. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase. J Clin Invest 1987;80:1289-1295.
26. Ogushi F, Hubbard RC, Vogelmeier C, Fells GA, Crystal RG. Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1- antitrypsin for neutrophil elastase. J Clin Invest 1991;87:1060-1065.
27. Alam S, Li Z, Janciauskiene S, Mahadeva R. Oxidation of Z α1- antitrypsin by cigarette smoke induces polymerization: a novel mechanism of early-onset emphysema. Am J Respir Cell Mol Biol 2011;45:261-269.
28. Mahadeva R, Atkinson C, Li Z, Stewart S, Janciauskiene S, Kelley DG, Parmar J, Pitman R, Shapiro SD, Lomas DA. Polymers of Z alpha1- antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am J Pathol 2005;166:377-386.
29. Carroll TP, Greene CM, O'Connor CA, Nolan AM, O'Neill SJ, McElvaney NG. Evidence for unfolded protein response activation in monocytes from individuals with alpha-1 antitrypsin deficiency. J Immunol 2010;184:4538-4546.
30. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha- 1 antitrypsin deficiency. Am J Respir Crit Care Med 2003;168:818-900.
31. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ 1997;75:397-415.
32. Stoller JK, Sandhaus RA, Turino G, Dickson R, Rodgers K, Strange C. Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem. Chest 2005;128:1989-1994.
33. Rodríguez P, Puga A, García-Sanz MT, Calvo U, Taboada JC, Gonzá lez-Barcala FJ. Delayed diagnosis of alpha-1 antitrypsin deficiency [in Spanish]. An Sist Sanit Navar 2011;34:105-108.
34. Wall M, Moe E, Eisenberg J, Powers M, Buist N, Buist AS. Long-term follow-up of a cohort of children with alpha-1-antitrypsin deficiency. J Pediatr 1990;116:248-251.
35. Carpenter MJ, Strange C, Jones Y, Dickson MR, Carter C, Moseley MA, Gilbert GE. Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency. Ann Behav Med 2007;33:22-28.
36. Dirksen A, Friis M, Olesen KP, Skovgaard LT, Sørensen K. Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT. Acta Radiol 1997;38:826-832.
37. Piitulainen E, Tornling G, Eriksson S. Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ). Thorax 1997;52:244-248.